The factory was established in 2004 with a registered capital of 30 million. It is a new technology enterprise integrating development, research, production and sales. The co***ny mainly produces pharmaceutical intermediates such as glacial acetic acid, tetraacetylribose, cytosine, acetyl hypoxanthine, diacetylpurine, etc., with production and sales orders, and sufficient orders.